Science Explorer Back to mapMap

Most cited papers from Patient Advocate Foundation

What are the most cited papers from Patient Advocate Foundation?

The most cited paper from Patient Advocate Foundation is "Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics" (Sarah S. Kalia, Kathy Adelman, Sherri J. Bale et al., 2016), with 1,725 citations. Next come "Breast Cancer Screening for Women at Average Risk" (1,670) and "Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)" (1,045).

Showing 50 of 59 papers. Every paper with more than 92 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics Sarah S. Kalia, Kathy Adelman, Sherri J. Bale et al. · Genetics in Medicine Open access 17 Nov 2016 1,725
2 Breast Cancer Screening for Women at Average Risk Kevin Charles Oeffinger, Elizabeth T. H. Fontham, Ruth Etzioni et al. · JAMA Open access 20 Oct 2015 1,670
3 Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Amylou Constance Dueck et al. · JAMA Oncology Open access 13 Aug 2015 1,045
4 Exercise is medicine in oncology: Engaging clinicians to help patients move through cancer Kathryn H. Schmitz et al. · CA A Cancer Journal for Clinicians Open access 16 Oct 2019 825
5 Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial Naomi Balzer Haas et al. · The Lancet Open access 8 Mar 2016 644
6 Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology Thomas W. Flaig et al. · Journal of the National Comprehensive Cancer Network Open access Mar 2020 638
7 Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors Pamela L. Kunz, Diane L. Reidy‐Lagunes, Lowell Brian Anthony et al. · Pancreas Open access 16 Apr 2013 589
8 Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology Nadeem R. Abu‐Rustum et al. · Journal of the National Comprehensive Cancer Network Feb 2023 578
9 Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology Jaffer A. Ajani et al. · Journal of the National Comprehensive Cancer Network Open access Apr 2023 570
10 ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG) David T. Miller, Kristy Lee, Wendy K. Chung et al. · Genetics in Medicine Open access 20 May 2021 570
11 Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update Nasser H. Hanna et al. · Journal of Clinical Oncology 28 Jan 2020 458
12 United States Valuation of EQ-5D-5L Health States Using an International Protocol Alan Simon Pickard, Ernest H. Law, Ruixuan Jiang et al. · Value in Health Open access 25 May 2019 404
13 NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024 Nadeem R. Abu‐Rustum et al. · Journal of the National Comprehensive Cancer Network Open access Dec 2023 386
14 ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper Arvind N. Dasari et al. · Nature Reviews Clinical Oncology ReviewOpen access 6 Jul 2020 380
15 Assessing research gaps and unmet needs in endometriosis Sawsan As‐Sanie, Rebecca Black, Linda C. Giudice et al. · American Journal of Obstetrics and Gynecology 18 Feb 2019 355
16 NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021 Daniel Aaron Pollyea et al. · Journal of the National Comprehensive Cancer Network 6 Jan 2021 333
17 Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline Mary T. Korytkowski, Ranganath Muniyappa, Kellie Antinori-Lent et al. · The Journal of Clinical Endocrinology & Metabolism Open access 12 Jun 2022 306
18 Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis Robert J. Fox et al. · New England Journal of Medicine Open access 29 Aug 2018 291
19 Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG) David T. Miller, Kristy Lee, ALLAN S. GORDON et al. · Genetics in Medicine Open access 20 May 2021 277
20 Bladder Cancer, Version 3.2024 Thomas W. Flaig et al. · Journal of the National Comprehensive Cancer Network May 2024 267
21 Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma Luciano J. Costa, Saurabh Chhabra, Eva Medvedova et al. · Journal of Clinical Oncology 13 Dec 2021 266
22 Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement Randall A. Oyer et al. · Journal of Clinical Oncology 19 May 2022 251
23 Homologous Recombination Deficiency: Concepts, Definitions, and Assays Mark D. Stewart et al. · The Oncologist Open access 2022 240
24 The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Diagnosis and Evaluation David A. Ginsberg, Timothy B. Boone, Anne Pelletier Cameron et al. · The Journal of Urology 8 Sep 2021 223
25 NCCN Guidelines Insights: Bladder Cancer, Version 5.2018 Thomas W. Flaig et al. · Journal of the National Comprehensive Cancer Network Open access Sep 2018 220
26 Pilot Feasibility Study of an Oncology Financial Navigation Program Veena Shankaran, Tony Leahy, Jordan Steelquist et al. · Journal of Oncology Practice 22 Dec 2017 217
27 British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults Anjan Dhar, Hasan Haboubi, Stephen Attwood et al. · Gut Open access 23 May 2022 214
28 Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology Jaffer A. Ajani et al. · Journal of the National Comprehensive Cancer Network May 2025 203
29 ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer Antonio Passaro et al. · Annals of Oncology Open access 14 Feb 2022 203
30 NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018 Shaji Kunnathu Kumar et al. · Journal of the National Comprehensive Cancer Network Open access 2018 203
31 Auditory Late Effects of Childhood Cancer Therapy: A Report From the Children's Oncology Group Satkiran S. Grewal, Thomas E. Merchant, Renee Reymond et al. · PEDIATRICS Open access 2 Mar 2010 203
32 Physician Workforce Disparities and Patient Care: A Narrative Review Julie K. Silver, Allison Bean, Chloe S. Slocum et al. · Health Equity ReviewOpen access Jul 2019 199
33 Real-Time Continuous Glucose Monitoring in Type 1 Diabetes: A Qualitative Framework Analysis of Patient Narratives John C. Pickup, Melissa Holloway, Kritika Samsi · Diabetes Care 31 Dec 2014 192
34 European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update Oscar Roberto Brouwer et al. · European Urology 9 Mar 2023 188
35 Informed Consent in the Medical Care of Transgender and Gender-Nonconforming Patients Timothy Cavanaugh, Ruben A. Hopwood, Cei Lambert · The AMA Journal of Ethic Open access Nov 2016 188
36 Changing the global obesity narrative to recognize and reduce weight stigma: A position statement from the World Obesity Federation Sarah Nutter et al. · Obesity Reviews Open access 17 Oct 2023 184
37 Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update Sharon Hermes Giordano, Maria Alice Franzoi, Sarah Temin et al. · Journal of Clinical Oncology Open access 31 May 2022 184
38 Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update Julia Bohlius, Kari Bohlke, Roberto Castelli et al. · Blood Advances Open access 10 Apr 2019 167
39 Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology Shaji Kunnathu Kumar et al. · Journal of the National Comprehensive Cancer Network Open access Dec 2023 157
40 The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up David A. Ginsberg, Timothy B. Boone, Anne Pelletier Cameron et al. · The Journal of Urology 8 Sep 2021 156
41 NCCN Guidelines® Insights: Distress Management, Version 2.2023 Michelle B. Riba et al. · Journal of the National Comprehensive Cancer Network Open access May 2023 142
42 Confidentiality, privacy, and security of genetic and genomic test information in electronic health records: points to consider Amy L. McGuire, Rebecca E. Fisher, Paul Cusenza et al. · Genetics in Medicine Open access Jul 2008 138
43 NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024 John A. Thompson et al. · Journal of the National Comprehensive Cancer Network Nov 2024 136
44 Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline Navneet Singh et al. · Journal of Clinical Oncology 11 Jul 2022 131
45 NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024 Joyce F. Liu et al. · Journal of the National Comprehensive Cancer Network Oct 2024 126
46 International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials Luciano J. Costa et al. · Leukemia Open access 11 Aug 2020 125
47 Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma Brian I. Rini, David F. McDermott, Hans J. Hammers et al. · Journal for ImmunoTherapy of Cancer Open access 11 Nov 2016 122
48 Recommendations for clinical implementation of blood‐based biomarkers for Alzheimer's disease Michelle M. Mielke et al. · Alzheimer s & Dementia Open access Oct 2024 117
49 Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline Navneet Singh et al. · Journal of Clinical Oncology 11 Jul 2022 116
50 Opioids and Chronic Pain: An Analytic Review of the Clinical Evidence Stephen E. Nadeau, Jeffrey K. Wu, Richard A Lawhern · Frontiers in Pain Research Open access 17 Aug 2021 108

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.